Bafna Pharmaceuticals Limited (BAFNAPH) — Capital Reinvestment Ratio
Latest as of September 2025:
1.76x
Bafna Pharmaceuticals Limited (BAFNAPH) has a Capital Reinvestment Ratio of 1.76x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs93.12 Million) in capital expenditures (Rs164.17 Million). See Bafna Pharmaceuticals Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.76x
Capex / Operating Cash Flow
Operating Cash Flow
Rs93.12 Million
INR
Capital Expenditures
Rs164.17 Million
INR
Data as of
Sep 2025
Most recent filing
Bafna Pharmaceuticals Limited Capital Reinvestment Ratio (2007–2026)
This chart tracks Bafna Pharmaceuticals Limited's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited (2007–2026)
Year-by-year Capital Reinvestment Ratio for Bafna Pharmaceuticals Limited from 2007 to 2026. For live market cap and broader valuation context, see BAFNAPH market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 2.11x | Rs118.27 Million | Rs249.03 Million | ▲ +88.1% |
| 2025 | 1.12x | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 1.64x | Rs94.85 Million | Rs155.78 Million | ▼ -1.0% |
| 2023 | 1.66x | Rs49.52 Million | Rs82.19 Million | ▲ +114.1% |
| 2022 | 0.78x | Rs97.28 Million | Rs75.41 Million | ▼ -69.4% |
| 2016 | 2.53x | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs101.06 Million | Rs187.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow